Navigation Links
Genpact and AstraZeneca Win Outsourcing Center and SSON Awards
Date:7/11/2012

NEW YORK, July 11, 2012 /PRNewswire/ -- Genpact Limited (NYSE: G), a global leader in business process and technology management, today announced that it has recently received two prestigious industry awards in conjunction with its client AstraZeneca.  The Outsourcing Center, as part of its 2012 Outsourcing Excellence Awards, presented the award for "Best F&A/Procurement" engagement to Genpact and AstraZeneca.  In addition, the Shared Services Outsourcing Network (SSON) awarded Genpact and AstraZeneca for "Excellence in People and Communication" at their 2012 Excellence Awards ceremony in Amsterdam.

(Logo: http://photos.prnewswire.com/prnh/20120501/NY98560LOGO )

Over the past three years, Genpact and AstraZeneca have enjoyed a very strong working partnership, enabling a seamless transition of extensive finance and accounting (F&A) services across more than 40 markets in multiple regions including Latin America and Europe. Genpact's engagement scope has also expanded to include diverse services such as learning and marketing solutions, supplier research, spend analytics, and process reengineering.  Genpact is also supporting AstraZeneca in their global finance process transformation roadmap to take AstraZeneca's finance operations to best-in-class in the pharmaceutical industry.  

The Genpact-AstraZeneca engagement has resulted in significant business outcomes for AstraZeneca's operations to date.  These include: the standardization of processes and increased visibility on metrics across F&A transactional processes from the outset; the ability to expand in high growth markets; measureable reductions in the cost of transactional F&A processes; and deployment of efficiency enhancing tools to enable the automation of finance processes and enhancement of customer satisfaction.

"Genpact is extremely proud of the work we do with AstraZeneca and we are honored to receive these awards from the Outsourcing Center and SSON," said Balkrishan 'BK' Kalra, senior vice president and business leader, Life Sciences at Genpact.  "The business impact that we have helped AstraZeneca achieve to date is a product of the incredibly collaborative and open partnership that we have and the joint commitment to meeting and exceeding AstraZeneca's business goals."

The Outsourcing Center's Outsourcing Excellence Award winners were judged by an independent panel of industry experts who evaluated numerous worldwide outsourcing relationships. SSON's annual Shared Services Excellence Awards honor, recognize and promote both captive and outsourced shared services that demonstrate winning practices, forming the industry benchmark in terms of performance excellence.

About Genpact

Genpact Limited (NYSE: G), a global leader in business process and technology management services, leverages the power of smarter processes, smarter analytics and smarter technology to help its clients drive intelligence across their enterprise.  Genpact's Smart Enterprise Processes (SEPSM) framework, its unique science of process combined with deep domain expertise in multiple industry verticals, leads to superior business outcomes. Genpact's Smart Decision Services deliver valuable business insights to its clients through targeted analytics, reengineering expertise, and advanced risk management. Making technology more intelligent by embedding it with process and data insights, Genpact also offers a wide range of technology services.  Driven by a passion for process innovation and operational excellence built on its Lean and Six Sigma DNA and the legacy of serving GE for more than 15 years, the company's 56,000+ professionals around the globe deliver services to its more than 600 clients from a network of 67 delivery centers across 18 countries supporting more than 30 languages. For more information, visit www.genpact.com.  Follow Genpact on Twitter, Facebook and LinkedIn

For more information:

Gail Marold (Genpact Media Relations)

gail.marold@genpact.com

+1 919-345-3899

Barbara Tate (For Genpact U.S.)

barbara.tate@ogilvy.com

+1 212-880-5338

Rupali Kathuria (For Genpact India)

rupali.kathuria@bm.com
+91 124 441 7589

 


'/>"/>
SOURCE Genpact Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
2. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
3. AstraZeneca And Cellworks Collaborate To Find New Treatment For Tuberculosis
4. Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference
5. Millstone Medical Outsourcing Hires New Vice President Quality
6. Emerging Trends in Medical Device Outsourcing and Contract Manufacturing
7. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
8. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
9. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
10. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
11. Elsevier Appoints New President of Elsevier CPM Resource Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
Breaking Medicine Technology:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
Breaking Medicine News(10 mins):